NCT06585410 2026-02-25Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell CarcinomaRegeneron PharmaceuticalsPhase 3 Recruiting369 enrolled
NCT05608291 2025-05-13A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With SurgeryRegeneron PharmaceuticalsPhase 3 Active not recruiting1,564 enrolled